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Abstract
Aims: To assess the determinants of exercise training-induced improvements in glucose control (HbA1C) including changes
in serum total adiponectin and FFA concentrations, and skeletal muscle peroxisome proliferator-activated receptor-c
coactivator-1a (PGC-1a) protein content.
Methods: A sub-cohort (n = 35; 48% men; 74% Caucasian) from the HART-D study undertaking muscle biopsies before and
after 9 months of aerobic (AT), resistance (RT), or combination training (ATRT).
Results: Changes in HbA1C were associated with changes in adiponectin (r =20.45, P= 0.007). Participants diagnosed with
type 2 diabetes for a longer duration had the largest increase in PGC-1a (r = 0.44, P= 0.008). Statistical modeling examining
changes in HbA1C suggested that male sex (P= 0.05), non-Caucasian ethnicity (P= 0.02), duration of type 2 diabetes (r = 0.40;
P,0.002) and changes in FFA (r = 0.36; P,0.004), adiponectin (r =20.26; P,0.03), and PGC-1a (r =20.28; P= 0.02) explain
,65% of the variability in the changes in HbA1C.
Conclusions: Decreases in HbA1C after 9 months of exercise were associated with shorter duration of diabetes, lowering of
serum FFA concentrations, increasing serum adiponectin concentrations and increasing skeletal muscle PGC-1a protein
expression.
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Introduction
Type 2 diabetes is as much a disease of disordered lipid
metabolism as a disease of abnormal glucose metabolism [1].
Failure to balance skeletal muscle lipid uptake (free fatty acids,
FFA) and storage in intracellular triacylglycerol with oxidation in
mitochondria is implicated in impaired insulin action [2].
Individuals with type 2 diabetes have a reduced plasma
adiponectin concentrations [3], reduced number of mitochondria
[4], and lower skeletal muscle gene/protein expressions of
peroxisome proliferator-activated receptor-c coactivator-1a
(PGC-1a), a key regulator of mitochondrial biogenesis [5] and
oxidative metabolism [6]. While increased PGC-1a has been
observed with acute exercise in humans [7], studies examining the
effects of chronic exercise training on adiponectin and PGC-1a
and their relationship to the change in glycemic control (HbA1C)
in individuals with type 2 diabetes are absent.
We recently demonstrated in the Health Benefits of Aerobic and
Resistance Training in individuals with type 2 Diabetes (HART-
D) study that 9 months of combined aerobic (AT) and resistance
(RT) training significantly reduced HbA1C levels in individuals
with type 2 diabetes [8]. The HART-D study also included AT
only and RT only training groups that, together with the
combined AT and RT training group, provide a unique
opportunity to examine the influence of factors known to influence
glycemic control, specifically serum FFA and adiponectin, skeletal
muscle PGC-1a protein content, and anthropometric/demo-
graphic measures. We therefore hypothesized that the change in
HbA1C after exercise would be independently associated with
serum FFA and adiponectin and the activation of skeletal muscle
PLOS ONE | www.plosone.org 1 June 2013 | Volume 8 | Issue 6 | e62973
mitochondrial biogenesis pathways as determined by PGC-1a
protein content.
Methods
Seventy-eight participants from the previously reported HART-
D study volunteered for and were enrolled into an ancillary study
that included the collection of muscle samples at baseline and after
9 months of intervention (Figure 1). Detailed methods as well as
inclusion/exclusion criteria are provided in the main outcomes
paper [8]]. Briefly, 262 sedentary individuals with type 2 diabetes
(HbA1C 6.5% to 11%, inclusive) aged 30 to 75 years were enrolled
into the study. Volunteers were excluded if body mass index was
$48 kg/m2, blood pressure was $160/100 mmHg, fasting
triglycerides were $500 mg/dL, urine protein was .100 mg/
dL, or serum creatinine was .1.5 mg/dL. In addition, volunteers
were excluded if they used an insulin pump or had a history of
stroke, advanced neuropathy or retinopathy, or any other serious
medical condition that prevented them from adhering to the
protocol or exercising safety. Of the original 78 participants, 23
were lost to follow-up due to non-compliance (,80% attendance)
with the study protocol leaving a total of 55 participants with both
baseline and follow-up data. An additional 10 participants
randomized to the control group were excluded from these
analyses. An additional 10 participants’ samples did not have
protein extracted. The final group of 35 participants (17 males and
18 females) aged 57.067.7 y are included in the present analysis.
The follow-up bloods draw and muscle biopsy for this ancillary
project occurred approximately 1 week after their last exercise
bout. The study was approved by the Pennington Biomedical
Research Center institutional review board and written informed
consent was obtained prior to study screening. The protocol for
this trial and supporting CONSORT checklist are available as
supporting information; see Checklist S1 and Protocol S1.
Intervention
HART-D participants were randomized to 9 months of aerobic
training (AT), resistance training (RT), a combination of both
(ATRT), or a non-exercise control group. The AT group exercised
3–4 times per week at 50–80% of VO2peak for a total energy
expenditure of 12 kcal?kg21?wk21. The RT group completed 3
days per week of 2 sets of 4 arm exercises, 3 sets of 3 leg exercises,
and 2 sets of back extension and abdominal crunch. The ATRT
group completed 3 sessions of AT (10 kcal?kg21?wk21) and 2
sessions of RT (1 set each of the RT exercises) per week in
conjunction with the Federal Physical Activity Guidelines [9].
Both exercise modalities were progressive in nature whereby the
treadmill speed and grade was increased to maintain the
appropriate intensity, reported in metabolic equivalent tasks
(METS) [10] and the weight lifted on each RT exercise was
increased when a participant could lift 12 repetitions on 2
consecutive sessions.
VO2max and body composition
Maximal cardiorespiratory fitness (VO2max) was assessed at
baseline and after 9 months of intervention on a treadmill
(Trackmaster 425, Newton, KS) with respiratory gases analyzed
using a True Max 2400 Metabolic Cart (Parvomedics, Salt Lake
City, UT). Peak oxygen uptake (VO2peak) was expressed relative to
fat-free mass (mL?kg FFM21?min21). Body composition was
measured by DXA (QDR 4500A, Hologic, Inc. Waltham, MA).
Blood analyses
Blood was collected by venipuncture in the morning after a 10-
hour fast at baseline and after the intervention. Blood samples
were placed into pre-chilled red-top tubes (serum FFA and
adiponectin) or EDTA collection tubes (plasma HbA1C) and
transported to the laboratory on ice (FFA and HbA1C). The blood
samples for FFA and HbA1C were cold centrifuged and the media
was immediately analyzed for FFA and HbA1C (Beckman Coulter
DXC600 Pro; Beckman Coulter Inc., Brea, CA). Blood collected
for total serum adiponectin (Linco, St. Charles, MO) concentra-
tions were transferred to the laboratory at room temperature,
centrifuged, and serum was stored at 280uC until run in a single
batch at the end of the trial. The intra-assay variation for HbA1C,
FFA, and adiponectin was 62.84%, 60.75%, and 66.21%,
respectively.
Figure 1. Consort diagram.
doi:10.1371/journal.pone.0062973.g001
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Muscle analysis
Muscle samples were obtained under local anaesthesia from the
vastus lateralis using the Bergstrom technique and immediately snap
frozen. Samples were homogenized by Kontes Duall tissue
grinders in RIPA buffer with a cocktail of protease and
phosphatase inhibitors (Sigma, St. Louis, MO). Total protein
content was quantified by BCA assay (Pierce, Rockford, IL) and
25 uL was added to each gel for determination of PGC-1a protein
content. PGC-1a protein content quantified relative to GAPDH
(Abcam, Cambridge, MA) was determined by Western blot using
an Odyssey 9120 Imaging System (LI-COR, Lincoln, NE) after
probing with goat anti-mouse IgG Alexa Fluor 680 (Invitrogen,
Carlsbad, CA). No data are available for the intra-assay variability
in PGC-1a or GAPDH protein content as replicates were not run
to preserve the remaining muscle tissue.
Randomization and blinding
After signing the informed consent for the ancillary study,
volunteers had baseline blood drawn and a muscle biopsy
performed. Volunteers were later randomized to an intervention
group according to the randomization schema within the main
HART-D trial resulting in unequal group randomization. The
nature of this intervention study prevents blinding of the exercise
intervention personnel. However, every effort was made to
maintain blinding of the assessment staff from the participant’s
intervention group.
Statistical analysis
Analysis of variance (ANOVA) was used to assess baseline group
differences (JMP 9.0.2, SAS Institute, Inc., Cary, NC) and
dichotomous variables were examined using a x2 test. All exercise
groups were collapsed into a single group for the remaining
analyses since no effect of exercise group was observed in the final
model (P=0.15), and the addition of exercise group to the final
model did not influence the other factors in the model. Linear
regression (Pearson r) was used to determine the relationships
among change (post-pre) scores. Baseline-adjusted changes in
anthropometric data, HbA1C, PGC-1a protein content, and
fasting adiponectin and free-fatty acids were determined using
analysis of covariance (ANCOVA) with group differences analyzed
using Student-t post-hoc tests. In addition, ANCOVA was used to
examine the relationships between changes in HbA1C and changes
in independent determinants (semi-partial correlation coefficients
(r)). To determine the relationship between changes in HbA1C and
changes in FFA, adiponectin, and PGC1a content, we first
adjusted for baseline HbA1C, sex, ethnicity, and duration of
diabetes; all variables that were adjusted for in the main outcomes
paper [8]. Furthermore, we aimed to determine whether weight,
body composition and/or fitness (VO2peak) further explained the
change in HbA1C or removed any of the existing parameters from
the model. Statistical significance was set at P,0.05 and data are
reported as mean (95%CI) unless noted otherwise.
Results
The average compliance for all exercise groups was 95.066.0%
(mean6SD; range= 80.6% to 100.0%). From Month 2 to Month
9, estimated average METS in AT (AT=5.761.0 to 7.261.0
METS and ATRT=5.060.7 to 5.861.0 METS) and total weight
lifted during RT (RT=56,422617,316 to 73,602625,631 lbs and
ATRT=1788166345 to 23,90969,532 lbs) increased similarly to
those reported in the main outcomes paper [8].
Baseline data for age, sex, diabetes duration, HbA1C body
composition, and VO2peak (ml/kg FFM) in this subset of HART-D
participants were similar to the main study for participants with an
overall compliance $80% (all P.0.18). However, the percent of
Caucasian participants was higher in this subset compared to the
main study (74.3% vs. 56.7%, respectively, P=0.045). Baseline
data and baseline-adjusted treatment effects are presented in
Table 1. Age was different across groups at baseline (P=0.02).
After training, change in VO2peak was not significantly different
between intervention groups in this cohort. Body weight was lower
after AT compared with RT (P,0.05) due to a tendency for RT to
increase FFM (P=0.05). The baseline-adjusted change in HbA1C
in this cohort was independent of treatment group (P=0.29). The
change in HbA1C adjusted for baseline HbA1C, age, ethnicity and
type 2 diabetes duration, were similar to those in the larger cohort
[8] albeit, not significant in this subset (exercise group effect,
P=0.60; 20.15% (20.58%, 0.27%), 20.34% (20.84%, 0.15%),
and 20.49%(21.03%, 0.05%) for RT, AT, and ATRT,
respectively). PGC-1a response tended to differ by intervention
group (P=0.08; Table 1).
Change in fasting serum adiponectin was inversely associated
with the change in HbA1C (r =20.45; P=0.007). Change in
HbA1C was not related to change in fasting serum FFA (r = 0.25;
P=0.15) or change in PGC-1a protein content (r = 0.05; P=0.80).
Participants with longer durations of type 2 diabetes had the
largest increase in PGC-1a (r = 0.44; P=0.008). Last, change in
VO2peak was inversely related with age (r =20.36; P,0.04). No
other significant relationships exist.
In the process of building our statistical model, we examined the
effect of change in serum FFA and adiponectin, and PGC-1a
protein content, separately, on changes in HbA1C after adjusting
for baseline HbA1C, sex, and ethnic group. The changes in serum
FFA (r = 0.33; P,0.02) and adiponectin (r =20.30; P,0.03) were
associated with the changes in HbA1C; however, change in PGC-
1a protein content did not reach statistical significance (r = 0.17;
P=0.24).
After adjusting for baseline HbA1C, changes in HbA1C were
related to type 2 diabetes duration (r = 0.40, P,0.002; Figure 2A),
changes in fasting serum FFA (r = 0.36, P,0.004; Figure 2B) and,
adiponectin (r =20.26, P,0.03; Figure 2C) levels, and skeletal
muscle PGC-1a protein (r =20.28, P=0.02; Figure 2D) inde-
pendent of sex (20.09% (20.36%, 0.17%) vs. 20.55% (20.92%,
20.17%); women vs. men, respectively; P=0.05) and ethnicity
(20.00% (20.23%, 0.23%) vs. 20.64% (21.09%, 20.19%),
Caucasian vs. non-Caucasian, respectively; P=0.02). Together,
these factors explained ,65% of the variance in the change in
HbA1C. The regression equation for the model is presented below.
Changes in fitness (VO2peak) and body composition did not
influence this model.
DHbA1C~{0:48 baseline HbA1Cð Þ{0:23 sexð Þ
z0:32 ethnic groupð Þz0:07 type 2 diabetes durationð Þ
z1:54 DFFAð Þ{0:06 Dadiponectinð Þ
{9:29 DPGC{1að Þz2:52
Conclusions
The novel finding of the present investigation was that the
changes in HbA1C after 9 months of exercise were independently
associated with the duration of type 2 diabetes and changes in
serum FFA and negatively associated with changes in serum
adiponectin and skeletal muscle PGC-1a.
Exercise Training and Glycemic Control
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The change in free-fatty acid concentration was a major
determinant of the change in glycemic control. Free-fatty acid
accumulation in the circulation may be the result of an imbalance
between skeletal muscle uptake and oxidation and defects in
adipose tissue insulin signaling [2]. Lipid oversupply to skeletal
muscle may cause insulin resistance through accumulation of
incompletely oxidized lipid species [11]. In the present investiga-
tion, improved balance between muscle lipid storage and
oxidation (less lipid species storage), as suggested by a decrease
in serum FFA, may be an important contributor to the
improvement in HbA1C.
We observed a strong inverse relationship between the changes
in adiponectin and the changes in HbA1C. Civitarese et al. recently
uncovered a pathway by which adiponectin increases skeletal
muscle PGC-1a, mitochondrial number and oxidative capacity
[12]. Adiponectin may also have beneficial effects, independent of
PGC-1a, by enhancing ceramidase activity, thus reducing the
amount of insulin desensitizing ceramides [13]. Our results
demonstrate a clinically relevant situation in which the change
in serum adiponectin was associated with an improvement in
HbA1C.
A recent review called for more effective and sophisticated
exercise prescriptions for the improvement of glucose control
through increasing intramuscular PGC-1a [14]. Studies demon-
strate increased PGC-1a with aerobic training [7], while others
show no effect or improvements with resistance training [15,16].
We tested different exercise modalities and only resistance training
had a tendency to increase PGC-1a content. Additionally, the
change in PGC-1a was greater in those with longer duration of
type 2 diabetes. In our final model, a greater increase in PGC-1a
and a shorter duration of type 2 diabetes were independently
associated with improved glycemic control. The main results from
the HART-D trial together with this ancillary study suggest that: 1)
a program of combined aerobic and resistance training has the
greatest effect on HbA1C; 2) resistance training may potentiate a
greater change in PGC-1a, and therefore, HbA1C; and 3)
individuals who start an exercise program soon after diagnosis
may see a larger effect on HbA1C levels.
Our investigation is limited by a small sample size with almost
50% of the participants assigned to the resistance training group.
However, we had adequate power to detect independent effects of
substrate (FFA), hormone (adiponectin) and muscle (PGC-1a)
changes on glycemic control after collapsing the exercise groups.
Drug changes were not controlled during the intervention period
resulting in a limitation whereby a tendency to reduce diabetes
medications after the combination intervention reduces the effect
on change in HbA1C levels. Furthermore, dietary assessments were
taken at baseline and follow-up by food frequency questionnaire
thus limiting our ability to determine the impact of dietary
modifications such as changes in caloric intake and dietary
composition. Finally, research suggests that GAPDH gene
transcription may be sensitive to treatments that may influence
PGC-1a protein content, including exercise-induced changes in
insulin sensitivity [17]. However, analysis of the crude and
GAPDH adjusted PGC-1a data yielded similar results providing
evidence that the effects noted in this manuscript were the result of
the exercise intervention on PGC-1a specifically and not
secondary changes in GAPDH. The primary strengths are a
well-controlled exercise training study with high adherence rates
and a wide range of changes in the dependent and independent
variables.
In summary, exercise in individuals with type 2 diabetes should
be initiated soon after diagnosis and include training programs
aimed at improving plasma substrate availability, endocrine
Table 1. Baseline participant characteristics and baseline adjusted changes in anthropometric data, HbA1C, PGC-1a protein
content, and fasting adiponectin and free-fatty acids after 9 months of exercise.
RT AT ATRT P-value
Baseline Change Baseline Change Baseline Change Baseline Change
n 16 11 8
Age, y 60.9 (7.6) 53.8 (6.6) 53.6 (6.4) 0.02a
Sex, male % 8 (50.0) 6 (54.6) 3 (37.5) 0.75
Ethnicity, Caucasian % 12 (75.0) 9 (81.8) 5 (62.5) 0.64
Type 2 Diabetes
Duration, y
9.5 (6.9) 6.0 (4.8) 5.9 (3.4) 0.20
Body Weight, kg 98.5 (15.1) 0.5 (20.7, 1.6) 90.5 (11.0) 21.6 (23.0, 20.2) 100.5 (22.3) 21.3 (22.9, 0.3) 0.32 ,0.05a
Fat Mass, % 37.4 (8.5) 20.9 (21.8, 0.0) 31.7 (8.8) 20.3 (21.4, 0.8) 38.4 (6.6) 20.9 (22.1, 0.4) 0.14 0.67
FFM, kg 61.6 (11.5) 1.3 (0.4, 2.2) 61.6 (9.3) 20.3 (21.4, 0.8) 62.3 (15.6) 20.1 (21.4, 1.2) 0.99 0.05
VO2peak, mL?kg
FFM21?min21
31.3 (4.6) 20.1 (22.1, 1.9) 34.7 (6.6) 2.0 (20.5, 4.5) 30.3 (3.3) 0.6 (22.2, 3.5) 0.13 0.43
HbA1C, % 7.1 (1.1) 0.0 (20.3, 0.4) 7.4 (1.4) 20.2 (20.7, 0.2) 6.9 (0.7) 20.4 (20.9, 0.1) 0.61 0.29
FFA, mmol/L 0.56 (0.21) 20.00
(20.11, 0.11)
0.66 (0.22) 0.04 (20.09, 0.17) 0.54 (0.24) 20.07
(20.22, 0.08)
0.47 0.56
Adiponectin, mg/mL 8.1 (4.2) 20.9 (22.9, 1.0) 6.7 (2.9) 0.3 (22.0, 2.6) 6.4 (3.9) 21.8 (24.5, 0.9) 0.47 0.47
PGC-1a/GAPDH, au 0.04 (0.04) 0.02 (0.00, 0.03) 0.05 (0.04) 0.00 (20.01, 0.02) 0.06 (0.04) 20.01
(20.03, 0.01)
0.53 0.08
All baseline data are means (SD), n (%), and baseline-adjusted change scores are mean (95%CI). Abbreviations: RT, resistance training; AT, aerobic training; ATRT,
combination of aerobic and resistance training; VO2 volume of oxygen consumed in mL per kg fat-free mass (FFM) per minute; HbA1C, glycated hemoglobin A1c; PGC-
1a/GAPDH, peroxisome proliferator-activated receptor-c coactivator-1a adjusted for glyceraldehyde 3-phosphate dehydrogenase protein content; FFA, free fatty acid.
aRT group significantly greater than greater than AT. Blank cells are not applicable.
doi:10.1371/journal.pone.0062973.t001
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function, and skeletal muscle factors shown to improve glycemic
outcomes.
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